Progyny, Inc.
PGNY

$1.3 B
Marketcap
$15.25
Share price
Country
$-0.74
Change (1 day)
$42.08
Year High
$13.39
Year Low

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

marketcap

Revenue of Progyny, Inc. (PGNY)

Revenue in 2023 (TTM): $1.09 B

According to Progyny, Inc.'s latest financial reports the company's current revenue (TTM) is $1.09 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Progyny, Inc.

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $1.09 B $238.8 M $64.47 M $70.69 M $62.04 M
2022 $786.91 M $167.33 M $24.94 M $24.44 M $30.36 M
2021 $500.62 M $112.14 M $33.64 M $32.44 M $65.77 M
2020 $344.86 M $70.06 M $10.25 M $8.68 M $46.46 M
2019 $229.68 M $45.51 M $11.81 M $-8,557,000 $-8,569,000
2018 $105.4 M $19.43 M $-1,569,000 $-6,893,000 $661 K
2017 $48.58 M $7.4 M $-9,446,000 $-12,459,000 $-12,452,000